2. Academic Validation
  3. PD169316, a specific p38 inhibitor, shows antiviral activity against Enterovirus71

PD169316, a specific p38 inhibitor, shows antiviral activity against Enterovirus71

  • Virology. 2017 Aug;508:150-158. doi: 10.1016/j.virol.2017.05.012.
Zhe Zhang 1,  Busen Wang 1,  Shipo Wu 1,  Yanbo Wen 1,  Xinyi Wang 1,  Xiaohong Song 1,  Jinlong Zhang 1,  Lihua Hou 2,  Wei Chen 3
Affiliations

Affiliations

  • 1 Beijing Institute of Biotechnology, Beijing 100071, China.
  • 2 Beijing Institute of Biotechnology, Beijing 100071, China. Electronic address: houlihua@sina.com.
  • 3 Beijing Institute of Biotechnology, Beijing 100071, China. Electronic address: cw0226@foxmail.com.
PMID: 28545002 DOI: 10.1016/j.virol.2017.05.012
Abstract

Enterovirus71 (EV71) is the major causative agent of hand, foot and mouth disease, which threatens the health of infants and young children. The expression of inflammatory cytokines induced by this viral Infection aggravate the illness. Here, we describe the anti-EV71 activity of a specific p38 inhibitor that regulates the p38-MAPK signaling pathway. PD169316 was specifically selected from a MAPK compound library due to its significant inhibitory effect on EV71 replication. PD169316 also reduced EV71-induced Apoptosis. Animal experiments showed that PD169316 can dampen the replication of EV71, reduce tissue damage and inhibit the release of inflammatory cytokines, thereby alleviating the severe diseases caused by EV71 in suckling mice.

Keywords

Antiviral therapy; EV71; PD169316; p38-MAPK.

Figures
Products
Inhibitors & Agonists
Other Products